TLOG (TetraLogic Pharmaceuticals) Receivables Turnover: 0.00 (As of Sep. 2016)


What is TetraLogic Pharmaceuticals Receivables Turnover?

TetraLogic Pharmaceuticals TLOG Receivables Turnover is 0.00 as of Sep. 2016.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. TetraLogic Pharmaceuticals's Revenue for the three months ended in Sep. 2016 was $0.00 Mil. TetraLogic Pharmaceuticals's average Accounts Receivable for the three months ended in Sep. 2016 was $0.00 Mil.

TetraLogic Pharmaceuticals  (OTCPK:TLOG) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

TetraLogic Pharmaceuticals Receivables Turnover Related Terms

TetraLogic Pharmaceuticals Receivables Turnover Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Receivables Turnover Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Receivables Turnover
0.00 0.00 0.00 0.00 0.00

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TLOG vs ARGSQ, GTHR, SOAN: Receivables Turnover Comparison

For the Biotechnology subindustry, TetraLogic Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TetraLogic Pharmaceuticals Receivables Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TetraLogic Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where TetraLogic Pharmaceuticals's Receivables Turnover falls into.


TetraLogic Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

TetraLogic Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Dec. 2015 is calculated as

Receivables Turnover (A: Dec. 2015 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2015 ) / ((Accounts Receivable (A: Dec. 2014 ) + Accounts Receivable (A: Dec. 2015 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

TetraLogic Pharmaceuticals's Receivables Turnover for the quarter that ended in Sep. 2016 is calculated as

Receivables Turnover (Q: Sep. 2016 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Sep. 2016 ) / ((Accounts Receivable (Q: Jun. 2016 ) + Accounts Receivable (Q: Sep. 2016 )) / count )
=0 / ((0 + 0) / 1 )
=0 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.00 mean?
TetraLogic Pharmaceuticals (TLOG) has a Receivables Turnover of 0.00 as of Sep. 2016. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Receivables Turnover too high?
TetraLogic Pharmaceuticals' current Receivables Turnover is 0.00.
How does TetraLogic Pharmaceuticals' Receivables Turnover compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Receivables Turnover of 0.00 can be compared against companies in the Biotechnology industry. The industry median Receivables Turnover is 5.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.27, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on TetraLogic Pharmaceuticals and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TetraLogic Pharmaceuticals's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Receivables Turnover is 0.00 as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.